Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Novartis Bioventures Ltd. investment portfolio

Novartis Bioventures Ltd. has made numerous investments in companies such as Amphista Therapeutics, Astronautx, and Artios Pharma within the Biotech sector.

unknown
Portfolio
6
Team
0

Portfolio (6)

CompanySectorCitySourceLast confirmed on
Amphista Therapeutics Limited
Amphista Therapeutics develops next‑generation targeted protein‑degradation medicines, employing its proprietary “Targeted Glue” technology to create drugs that selectively destroy disease‑causing proteins. Its products are directed at patients with high‑unmet‑need diseases where conventional therapies are insufficient.
Healthcare & Life SciencesCambridgeConfirmed2025-12-06
Artios Pharma Limited
Artios Pharma Limited develops DNA‑damage‑response‑based cancer therapeutics. Its pipeline includes the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043, targeting hard‑to‑treat solid tumours.
Healthcare & Life SciencesCambridgeConfirmed2025-12-28

Sign up to see the full portfolio

+4 more companies

Sign up

Shareholding changes (9)

Novartis Bioventures Ltd.'s positions across portfolio companies
2026

Sign up free to see when this investor has bought or sold shares.

+7 more changes

Sign up

Articles (2)